Plasmin promotes an endothelium-dependent adhesion of neutrophils: Involvement of platelet activating factor and P-selectin

Circulation

Volumn 93, Issue 12, 1996, Pages 2152-2160

  Montrucchio, G ^a   Lupia, E ^a   De Martino, A ^a   Silvestro, L ^b   Rizea Savu, S ^a   Cacace, G ^a,c,d   De Filippi, P G ^c   Emanuelli, G ^a   Camussi, G ^a,c,d,e  

^a UNIVERSITY OF TURIN   (Italy)

^b Instituts F Biomed Pharmazeut F   (Germany)

^c MOLINETTE HOSPITAL   (Italy)

^d UNIVERSITY OF PAVIA   (Italy)

^e Dipartimento di Scienze   (Italy)

Author keywords

cells; endothelium; leukocytes; platelet derived factors

Indexed keywords

BEPAFANT; CD18 ANTIGEN; MONOCLONAL ANTIBODY; PADGEM PROTEIN; PLASMIN; THROMBOCYTE ACTIVATING FACTOR;

ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; CATTLE; CONTROLLED STUDY; CORONARY ARTERY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; LEUKOCYTE ADHERENCE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; VASCULAR ENDOTHELIUM;

EID: 0029891405     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.93.12.2152     Document Type: Article

References (47)

1. Montrucchio G, Bergerone S, Bussolino F, Alloatti G, Silvestro L, Lupia E, Cravetto A, Di Leo M, Emanuelli G, Camussi G. Streptokinase induces intravascular release of platelet-activating factor in patients with acute myocardial infarction and stimulates its synthesis by cultured human endothelial cells. Circulation. 1993;88: 1476-1483.
2. Torr SR, Haskel EJ, Von Voigtlander PF. Bergmann SR, Abendschein DR. Inhibition of cyclic flow variations and rcocclusion after thrombolysis in dogs by a novel antagonist of platelet-activating factor. J Am Coll Cardiol. 1991;18:1804-1810.
3. Frescott SM, Zimmerman GA, McIntyre TM. Platelet-activating factor. J Biol Chem. 1990;265:17381-17384.
4. McManus LM, Woodard DS, Deavers SI, Pinckard RN. PAF molecular heterogeneity: pathobiological implications. Lab Invest. 1993;69:639-650.
5. Mickelson JK, Simpson PJ, Lucchesi BR. Myocardial dysfunction and coronary vasoconstriction induced by platelet-activating factor in the post-infarcted rabbit isolated heart. J Mol Cell Cardiol. 1988; 20:547-561.
6. Montrucchio G, Alloatti G, Mariano F, De Paulis R, Comino A, Emanuclli G, Camussi G. Role of platelet-activating factor in the reperfusion injury of rabbit ischemic heart. Am J Pathol. 1990;134: 71-83.
7. Maruyama M, Farber NE, Vercellotti GM, Jacob HS, Gross OJ. Evidence for a role of platelet activating factor in the pathogenesis of irreversible but not reversible myocardial injury after reperfusion in dogs. Am Heart J. 1990;120:510-520.
8. Ma X, Weyrich AS, Krantz S, Lefer AM. Mechanisms of the cardioprotective actions of WEB-2170, bepafant, a platelet activating factor antagonist, in myocardial ischemia and reperfusion. J Pharmacol Exp Ther. 1992;260:1229-1236.
9. Montrucchio G, Alloatti G, Mariano F, Comino A, Cacace G, Polloni R, De Filippi PG, Emanuelli G, Camussi G. Role of platelet-activating factor in polymorphonuclear neutrophil recruitment in reperfused ischemic rabbit heart. Am J Pathol. 1993;142:471-480.
10. Lucchesi BR. Modulation of leukocyte-mediated myocardial reperfusion injury. Annu Rev Physiol. 1990;52:561-576.
11. Mullane KM. Neutrophil and endothelial changes in reperfusion injury. Trends Cardiovasc Med. 1991;1:282-289.
12. Bienvenu K, Granger DN. Leukocyte adhesion in ischemia/ reperfusion. Blood Cells. 1993;19:279-289.
13. Zimmerman GA, Prescott SM, McIntyre TM. Endothelial cell interactions with granulocytes: tethering and signaling molecules. Immunol Today. 1992;13:93-100.
14. Zimmerman GA, McIntyre TM, Prescott SM. Thrombin stimulates the adherence of neutrophils to human endothelial cells in vitro. J Clin Invest. 1985;76:2235-2246.
15. Lewis MS, Whatley RE, Cain P, McIntyre TM, Prescott SM, Zimmerman GA. Hydrogen peroxide stimulates the synthesis of platelet-activating factor hy endothelium and induces endothelial cell-dependent neutrophil adhesion. J Clin Invest. 1988;82:2045-2055.
16. Arnould T, Michiels C, Remade J. Increased PMN adherence on endothelial cells after hypoxia: involvement of PAF, CD18/CD11b, and ICAM-1. Am J Physiol. 1993;264:C1102-C1110.
17. Silvestro L, Ruikun C, Sommer F, Duc TM, Biancone L, Montrucchio G, Camussi G. Platelet-activating factor-induced endothelial cell expression of adhesion molecules and modulation of surface glycocalyx, evaluated by electron spectroscopy chemical analysis. Semin Thromb Hemost. 1994;20:214-222.
18. Loran DE, Patel KD, McIntyre TM, McEver RP, Prescott SM, Zimmerman GA. Coexpression of GMP-140 and PAF by endothelium stimulated by histamine or thrombin: a juxtacrine system for adhesion and activation of neutrophils. J Cell Biol. 1991;115: 223-234.
19. Humphrey DM, McManus LM, Satouchi K, Hanahan DJ, Pinckard RN. Vasoactive proprieties of acetyl glyceryl ether phosphorylcholine and analogues. Lab Invest. 1982;46:422-427
20. Bussolino F, Camussi G, Aglietta M, Braquet P, Bosia A, Pescarmona GP, Sanavio F, D'Urso M, Marchisio PC. Human endothelial cells are target for platelet-activating factor: platelet-activating factor induces changes in cytoskeleton structures. J Immunol. 1987;139:2439-2446.
21. Kobayashi I, Kim D, Hobson RW II, Duran WN. Platelet-activating factor modulates microvascular transport by stimulation of protein kinase C. Am J Physiol. 1994;266:H1214-H1220.
22. Rudd MA, Johnstone MT, Rabbani LE, George D, Ware JA, Loscalzo J. Thrombolytic therapy causes an increase in vascular permeability that is reversed by 1-deamino-8-d-vasopressin. Circulation. 1991;84:2568-2573.
23. Bussolino F, Sironi M, Bocchietto E, Mantovani A. Synthesis of platelet-activating factor by polymorphonuclear neutrophils stimulated with interleukin-8. J Biol Chem. 1992;267:4598-4603.
24. Silvestro L, Da Col R, Scappaticci E, Libertucci D, Biancone L, Camussi G. Development of an HPLC-MS technique, with an ionospray interface, for the determination of PAF and Lyso-PAF in biological samples. J Chromatogr. 1993;647:261-269.
25. Heuer HO, Casals-Stenzel J, Muacevic G, Weber KH. Pharmacologic activity of bepafant (WEB2170), a new and selective tetrazepinoic antagonist of platelet-activating factor. J Pharmacol Exp Ther. 1990;225:962-968.
26. Johnston GI, Kurosky A, McEver RP. Structural and biosynthetic studies of the granule membrane protein, GMP-140 from human platelets and endothelial cells. J Biol Chem. 1989;154:1816-1823.
27. Camussi G, Aglietta M, Malavasi F, Tetta C, Piacibello W, Sanavio F, Bussolino F. The release of platelet activating factor from human endothelial cells in culture. J Immunol. 1983;131:2397-2403.
28. Yannariello-Brown J, Wewer U, Liotta L, Madri JA. Distribution of a 69-KD Laminin-binding protein in aortic and microvascular endothelial cells: modulation during cell attachment, spreading, and migration. J Cell Biol. 1988;106:1773-1786.
29. Camussi G, Tetta C, Bussolino F, Baglioni C. Synthesis and release of platelet-activating factor is inhibited by plasma alpha1-proteinase inhibitor or by alpha1-antichimotripsin and is stimulated by proteinases. J Exp Med. 1988;168:1293-1306.
30. Spertini O, Luscinskas FW, Gimbrone MA, Tedder TF. Monocyte attachment to activated human vascular endothelium in vitro is mediated by leukocyte adhesion molecule-1 (L-selectin) under non-static conditions. J Exp Med. 1992;172:1789-1792.
31. Wulf EA, Deboden F, Bantz A, Faulstich H, Wieland T. Fluorescent phallotoxin: a tool for the visualization of cellular actin. Proc Natl Acad Sci U S A. 1979;76:4498-4502.
32. Rotrosen D, Gallin JI. Histamine type I receptor occupancy increases endothelial cytosolic calcium, reduces F-actin and promotes albumin diffusion across cultured endothelial monolayers. J Cell Biol. 1986;103:2379-2387.
33. Bussolino F, Arese M, Silvestro L, Soldi R, Benfenati E, Sanavio F, Aglietta M, Bosia A, Camussi G. Involvement of a serine protease in the synthesis of platelet-activating factor by endothelial cells stimulated by tumor necrosis factor-α or interleukin-1α. Eur J Immunol. 1994;24:3131-3139.
34. Clay KL. Quantitation of platelet-activating factor by gas chromatography-mass spectrometry. Methods Enzymol. 1992;187:134-142.
35. Triggiani M, Hubbard WC, Chilton FH. Synthesis of 1-acyl-2-acetyl-sn-glycero-3-phosphocholine by an enriched preparation of the human lung mast cell. J Immunol. 1990;144:4773-4780.
36. Triggiani M, Schleimer RP, Warner JA, Chilton FH. Differential synthesis of 1-acyl-2-acetyl-sn-glycero-3-phosphocholine and platelet-activating factor by human inflammatory cells. J Immunol. 1991; 147:660-666.
37. Clay KL, Johnson C, Worthen GS. Biosynthesis of platelet activating factor and 1-O-acyl-analogues by endothelial cells. Biochim Biophys Acta. 1991;1094:43-50.
38. Lo SK, Ryan TJ, Gilboa N, Lai L, Malik AB. Role of catalytic and lysine-binding sites in plasmin-induced neutrophil adherence to endothelium. J Clin Invest. 1989;84:793-801.
39. Triggiani M, Goldman DW, Chilton FH. Biological effects of 1-acyl-2-acetyl-sn-glycero-3-phosphocholine in the human neutrophil. Biochim Biophys Acta. 1991;1084:41-47.
40. Heller R, Bussolino F, Ghigo D, Garbarino G, Pescarmona G, Till U, Bosia A. Human endothelial cells are target for platelet-activating factor, II: platelet-activating factor induces platelet-activating factor synthesis in human umbilical vein endothelial cells. J Immunol. 1992;149:3682-3688.
41. Murohara T, Buerke M, Lefer AM. Polymorphonuclear leukocyte-induced vasocontraction and endothelial dysfunction: role of selectins. ArteriosclerThromb. 1994;14:1509-1519.
42. Weyrich AS, Ma X-I, Lefer DJ, Albertine KH, Lefer AM. In vivo neutralization of P-selectin protects feline heart and endothelium in myocardial ischemia and reperfusion injury myocardial ischemia and reperfusion injury. J Clin Invest. 1993;91:2620-2629.
43. x analog attenuates neutrophil accumulation and myocardial necrosis after ischemia and reperfusion. Circulation. 1994; 90:2390-2401.
44. Mentzer RL, Budzynski AZ, Sherry S. High-dose, brief duration intravenous infusion of streptokinase in acute myocardia infarction: description of effects in the circulation. Am J Cardiol. 1986;57: 1220-1226.
45. Owen J, Friedman KD, Grossman BA, Wilkins C, Berke AD, Powers ER. Thrombolytic therapy with tissue plasminogen activator or streptokinase induces transient thrombin activity. Blood. 1988;72:616-620.
46. Davies SW, Ranjadayalan K, Wickens DG, Dormandy TL, Timmis AD. Lipid peroxidation associated with successful thrombolysis. Lancet. 1990;335:741-743.
47. Gasic AC, McGuire G, Krater S, Farhood AI, Goldstein MA, Smith CW, Entman ML, Taylor AA. Hydrogen peroxide pretreatment of perfused canine vessels induces ICAM-1 and CD18-dependent neutrophil adherence. Circulation. 1991;84:2154-2166.